Methylene Blue for ADHD: What the Research Says About Focus, Attention, and Mitochondrial Energy

Methylene blue for ADHD is a common question in nootropic forums, usually from people who want better focus without the side effects of a stimulant medication. The straight answer is that no one has tested methylene blue in people diagnosed with ADHD. What exists is a small set of brain-imaging trials in healthy adults, a body of animal work, and a set of drug labels that make one thing very clear: methylene blue must not be combined with the main ADHD medications.

This page sets out what that research does and does not show, how methylene blue acts in the brain, and why the interaction risk is the most important part of the story. NooBlue sells methylene blue capsules, gummies and drops, so we have a commercial interest in the subject. We do not sell methylene blue for ADHD, and nothing here is a claim that it helps with it. Written by the NooBlue editorial team.

Methylene Blue for ADHD: No Clinical Trials Yet

When we searched PubMed for studies that mention methylene blue together with ADHD, attention deficit or hyperactivity in the title or abstract, the search returned no trial of methylene blue in people with the condition. ClinicalTrials.gov listed no registered study pairing the two either. Several sellers still describe methylene blue as an ADHD aid, and some forum posts report good experiences, but none of that is controlled evidence and it does not tell you whether the effect was real.

That leaves three kinds of evidence, each one step further from the question people are asking:

• Healthy-adult imaging trials. A single large oral dose changed brain activity and memory performance in volunteers with no ADHD diagnosis.
• Animal and cell studies. These describe how methylene blue works in mitochondria and show that its effects flip at higher doses.
• Drug labels and case reports. These document the interactions that make methylene blue unsafe alongside common medicines.

We also publish a comparison of methylene blue products for adults who want focus support. Our methylene blue focus and attention roundup covers doses and paperwork by brand, with the same warnings as this page.

What the Human Research Does Show

The most cited study is a randomized, double-blind, placebo-controlled trial published in Radiology in 2016. Researchers at the University of Texas enrolled 26 healthy adults aged 22 to 62. Each took a single oral dose of 280 mg of methylene blue, about 4 mg/kg, or a placebo. Functional MRI was run before the dose and again one hour later, while the volunteers did a sustained-attention task and a short-term memory task (full text, PMC5084971).

After methylene blue, responses in the insular cortex rose during the attention task, and activity in prefrontal, parietal and occipital areas rose during the memory task. Correct responses during memory retrieval increased by 7% (Rodriguez et al., Radiology, 2016). A 2017 follow-up from the same group used the same single 280 mg dose and found lower blood flow in a task-related network during a visual-motor task, plus stronger resting-state connectivity between regions tied to perception and memory (Rodriguez et al., Brain Imaging and Behavior, 2017).

Four limits matter, and they are why these results do not apply to ADHD:

• No participant had an ADHD diagnosis. The trials recruited healthy volunteers.
• One dose, one hour. Nobody measured what happens over weeks of daily use.
• The dose was large. 280 mg is 56 times one 5 mg NooBlue capsule and 28 times one 10 mg gummy. There is no imaging data at supplement doses.
• Brain activity is not the same as daily function. A stronger signal on a scan and a 7% gain on one lab task do not show changes in work, school or home life.

For the wider picture on focus and mental energy in adults, see our guide to methylene blue for brain fog, and our summary of what the research on methylene blue benefits shows.

How Methylene Blue Acts in the Brain

An extra electron carrier in the mitochondria

Methylene blue can pick up electrons and pass them on. A 2018 review in Molecular Neurobiology describes it rerouting electrons in the mitochondrial chain directly from NADH to cytochrome c, which increases the activity of complex IV (Tucker et al., 2018). This is the mechanism behind most of the interest in methylene blue for mental energy. Our explainer on how methylene blue works goes through it step by step.

An MAO-A inhibitor

Methylene blue is also a potent, reversible inhibitor of monoamine oxidase A, one of the enzymes that break down monoamine messengers in the body (Ramsay et al., British Journal of Pharmacology, 2007). Its main metabolite, azure B, inhibits the same enzyme about six times more potently in lab tests (Petzer et al., 2012). This second action is the reason for every interaction warning further down the page.

Effects that flip at higher doses

More is not better with methylene blue. A review of the animal memory research by Rojas, Bruchey and Gonzalez-Lima in Progress in Neurobiology describes a hormetic dose response, with opposite effects at low and high doses (Rojas et al., 2012). A zebrafish study shows the pattern clearly. Fish exposed to 0.5 µM remembered a maze better than fish on higher doses, fish on 5.0 µM did no better than controls, and fish on 10.0 µM did worse than those on lower doses (Echevarria et al., Zebrafish, 2016). Fish are not people, but the direction of the curve is why doses above the label make little sense.

Not a stimulant

Amphetamine medicines increase the release of norepinephrine and other monoamines from nerve endings, as the lisdexamfetamine label describes. The research we reviewed describes no such releasing action for methylene blue. Its two documented actions are the electron-carrier role and MAO-A inhibition. That is also why the two do not mix: an MAO inhibitor slows the breakdown of the very messengers a stimulant releases. Our comparison of methylene blue vs Adderall sets out the differences in detail.

Why Methylene Blue and ADHD Medications Do Not Mix

This is the section that matters most for anyone reading this page with a prescription. The manufacturers’ own prescribing information is direct:

• Mixed amphetamine salts (Adderall XR). The label rules out use in patients taking MAO inhibitors or within 14 days of stopping one, and names linezolid and intravenous methylene blue as examples, because of an increased risk of hypertensive crisis (Adderall XR prescribing information).
• Lisdexamfetamine (Vyvanse). The label carries the same restriction and names the same two examples. It adds that MAOI antidepressants slow amphetamine metabolism and can cause headaches and other signs of hypertensive crisis, with toxic neurological effects that are sometimes fatal (Vyvanse prescribing information).
• Atomoxetine (Strattera). The label calls the drug contraindicated in patients taking MAO inhibitors, “including MAOIs such as linezolid or intravenous methylene blue,” or in patients who stopped one within 14 days. It notes reports of serious, sometimes fatal reactions when drugs that affect brain monoamines are combined with MAO inhibitors (Strattera prescribing information).
• Methylphenidate (Ritalin LA). The label rules out use alongside an MAO inhibitor or within 14 days of one, and warns that combining MAO inhibitors with CNS stimulants can cause hypertensive crisis (Ritalin LA prescribing information).

The labels name intravenous methylene blue, and no study has measured how much a 5 mg oral serving inhibits MAO-A. That gap is not a reason to experiment. Methylene blue is a potent MAO-A inhibitor at the concentrations studied, and until someone shows a safe threshold, the only safe position is not to combine it with any of these medicines.

Taking methylene blue only on days off a stimulant does not get around the problem, and some forum posts suggest exactly that. The labels ask for a 14-day gap after an MAO inhibitor, and the prescribing information for the methylene blue injection gives a half-life of about 24 hours (ProvayBlue prescribing information). Our methylene blue half-life guide explains why a dose lingers.

Antidepressants and other serotonergic medicines

Many adults with ADHD also take an antidepressant, and methylene blue must not be combined with that medicine either. A systematic review in Psychosomatics found 26 patients who developed an acute confusional state after a methylene blue infusion. Of those, 24 were taking a serotonin reuptake inhibitor and one was taking clomipramine, and serotonin syndrome was a possible diagnosis in all 25 (Ng and Cameron, Psychosomatics, 2010). The methylene blue injection’s label warns against SSRIs, SNRIs and MAOIs, and adds that opioids and dextromethorphan may increase the risk.

If you take any prescription medicine, speak to your prescriber or pharmacist before trying methylene blue. Our guides to methylene blue and serotonin syndrome, what not to take with methylene blue and methylene blue drug interactions list the drug classes to check.

Who Should Not Take Methylene Blue

These warnings apply to every format and every dose, whatever the reason for taking it:

• Anyone taking ADHD medication, including amphetamines, lisdexamfetamine, methylphenidate and atomoxetine, for the reasons above.
• Anyone taking serotonergic medicines, including SSRIs, SNRIs and MAOIs.
• People with G6PD deficiency. The injection is contraindicated in G6PD deficiency because of the risk of hemolytic anemia. See our G6PD guide.
• Anyone pregnant or breastfeeding. The injection’s label states that methylene blue may cause fetal harm, and advises stopping breastfeeding during treatment and for up to 8 days afterwards.
• Children. This page is about adults. Decisions about a child’s attention or behavior belong with the child’s doctor, and methylene blue supplements are not for children.

Our full list is in who should not take methylene blue, and common reactions are covered in our methylene blue side effects guide.

Methylene Blue for Everyday Focus in Adults Without These Risks

Some adults with no diagnosis, on no interacting medicines, take methylene blue as part of a routine for mental energy. The research above does not show what a supplement serving does for focus, so any benefit at 5 or 10 mg is unproven. If none of the warnings applies to you and you still want to try it, three habits keep the risk low:

• Stay at the lowest serving on the label. The dose-response research runs the wrong way at high doses. Our guide to how many mg of methylene blue per day covers daily amounts.
• Keep the routine consistent. Take it the same way each day. Our capsule label says to take one capsule daily with food.
• Know what to expect on timing. The imaging trials scanned at one hour because earlier data showed whole-blood levels peaking then. See how long methylene blue takes to work and our breakdown of methylene blue absorption.

The three NooBlue formats differ in dose and how you take them. Prices as of Sep 2026.

The capsules give a fixed 5 mg with nothing to measure. The drops let you adjust in 0.5 mg steps, and our guide to taking methylene blue drops explains measuring and mixing. The gummies carry the largest single serving at 10 mg. Contract Testing Laboratories of America analyzed our methylene blue ingredient for identity and four heavy metals. That report covers the raw ingredient, not each finished batch, and it does not state a purity percentage. Everything is in the NooBlue shop.

If you are weighing other options for focus without a stimulant, our roundup of supplements for energy and focus without stimulants compares them, and our methylene blue vs modafinil page covers another common comparison.

Frequently Asked Questions

Does methylene blue help with focus?

In healthy adults, a single 280 mg dose raised brain activity during attention and memory tasks and improved memory retrieval by 7% an hour later. That dose is 56 times one 5 mg capsule, and no trial has tested methylene blue for focus at supplement doses or in people with ADHD.

Does methylene blue boost dopamine?

No human study has measured dopamine changes from methylene blue at supplement doses. It inhibits MAO-A, an enzyme that breaks down monoamine messengers, and the research links that action to serotonin toxicity when it is combined with serotonergic drugs. That same action is why it must not be taken with amphetamines or other stimulants.

Why do I feel so good on methylene blue?

We cannot say, and no study has measured how people feel on 5 or 10 mg. Methylene blue does act on MAO-A, the enzyme behind its serotonin interaction, so a change in how you feel is a reason to review everything else you take with a doctor or pharmacist. It is not a reason to raise the dose.

Is there a natural supplement for ADHD that can replace medication?

We cannot point to any supplement as a proven option for ADHD, and methylene blue has never been tested for it. Supplements do not replace an assessment and a care plan from a doctor. If you already take ADHD medication, check any supplement with your prescriber first, and never combine it with methylene blue.

Can you take methylene blue with Adderall or Vyvanse?

No. The Adderall XR and Vyvanse labels both rule out use with MAO inhibitors or within 14 days of one, and both name intravenous methylene blue among those inhibitors because of the risk of hypertensive crisis. Our interactions guide covers other stimulants.

Can children with ADHD take methylene blue?

No. There is no research on methylene blue for attention in children, and methylene blue supplements are not for children. Questions about a child’s attention belong with the child’s doctor.

Is methylene blue a stimulant?

No. Its documented actions are as an electron carrier in the mitochondria and as an MAO-A inhibitor. It does not share the monoamine-releasing action of amphetamine medicines, which is also why the two are unsafe together.

Can I take methylene blue every day?

Long-term human data at supplement doses is limited. With a half-life of about 24 hours, daily doses overlap, so staying at the lowest serving on the label matters more than timing. Our analysis of whether methylene blue is safe to take daily goes into the evidence, and nobody taking ADHD or serotonergic medication should take it at all.

Sources

1. Rodriguez P, Zhou W, Barrett DW, et al. Multimodal randomized functional MR imaging of the effects of methylene blue in the human brain. Radiology. 2016;281(2):516-526. PubMed 27351678
2. Rodriguez P, Singh AP, Malloy KE, et al. Methylene blue modulates functional connectivity in the human brain. Brain Imaging and Behavior. 2017;11(3):640-648. PubMed 26961091
3. Tucker D, Lu Y, Zhang Q. From mitochondrial function to neuroprotection: an emerging role for methylene blue. Molecular Neurobiology. 2018;55(6):5137-5153. PubMed 28840449
4. Ramsay RR, Dunford C, Gillman PK. Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction. British Journal of Pharmacology. 2007;152(6):946-951. PubMed 17721552
5. Petzer A, Harvey BH, Wegener G, Petzer JP. Azure B, a metabolite of methylene blue, is a high-potency, reversible inhibitor of monoamine oxidase. Toxicology and Applied Pharmacology. 2012;258(3):403-409. PubMed 22197611
6. Rojas JC, Bruchey AK, Gonzalez-Lima F. Neurometabolic mechanisms for memory enhancement and neuroprotection of methylene blue. Progress in Neurobiology. 2012;96(1):32-45. PubMed 22067440
7. Echevarria DJ, Caramillo EM, Gonzalez-Lima F. Methylene blue facilitates memory retention in zebrafish in a dose-dependent manner. Zebrafish. 2016;13(6):489-494. PubMed 27482828
8. Ng BK, Cameron AJ. The role of methylene blue in serotonin syndrome: a systematic review. Psychosomatics. 2010;51(3):194-200. PubMed 20484716
9. Adderall XR (mixed amphetamine salts) prescribing information, revised 4/2026. DailyMed
10. Vyvanse (lisdexamfetamine dimesylate) prescribing information, revised 4/2026. DailyMed
11. Strattera (atomoxetine) prescribing information, revised 6/2026. DailyMed
12. Ritalin LA (methylphenidate hydrochloride) prescribing information, revised 9/2025. DailyMed
13. ProvayBlue (methylene blue) injection prescribing information, revised 2/2024. DailyMed
14. NooBlue product pages and quality page (label amounts and the CTLA ingredient report), read Sep 2026. nooblue.com/quality